S
Scivita Medical
Reusable and single-use endoscopic imaging systems
About Scivita Medical
Scivita Medical (新光维医疗科技股份有限公司) develops reusable and single-use endoscopic visualization platforms spanning laparoscopy, uroscopy, gynecology, and ENT. Founded in 2016 and based in Suzhou, the company positions optical diagnosis/treatment, multi-dimensional imaging, high-performance materials, and precision manufacturing as core capabilities. Public materials highlight domestic hospital adoption and international registration workstreams for disposable and reusable endoscope families.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 27
- Open positions
- 2
- Dealroom signal
- 70.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Tech for Medical Professionals, Hard Tech, DT and LS, science-based
- Technology
- Hardware, 3D Technology, Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Aug 2021 | $55M | $220M | Lilly Asia Ventures · GL Ventures · Matrix Partners China · Hudson Bay Capital Management | — |
| SERIES AOther financing | Apr 2021 | $55M | $220M | Chengwei Capital · Matrix Partners China · Medtronic · Lilly Asia Ventures | — |
Growth signals
Latest recorded traffic for Scivita Medical is 800 monthly website visits, up 281% over the last three months. Scivita Medical's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Scivita Medical in the Suzhou Shi ecosystem
The Scivita Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A8 investors entered at this stage
Lilly Asia Ventures
Chengwei Capital
Matrix Partners China
Medtronic
GL Ventures- SIShanghai Innochip Investment
Hudson Bay Capital Management- PCPrime Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Scivita Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Scivita Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









